Acurx Pharmaceuticals (ACXP) Earnings Date, Estimates & Call Transcripts $0.40 -0.01 (-3.11%) Closing price 04:00 PM EasternExtended Trading$0.39 -0.01 (-2.06%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acurx Pharmaceuticals Earnings Summary Acurx Pharmaceuticals posted Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.11, which beat analysts' consensus estimates of -$0.14 by $0.03. With a trailing EPS of -$0.70, Acurx Pharmaceuticals' earnings are expected to decrease next year, from ($0.89) to ($2.06) per share. Upcoming Q2 Earnings DateAug. 8Before Market OpensEstimatedConsensus EPS (May. 12) -$0.14 Actual EPS (May. 12) -$0.11 Beat By $0.03 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)ACXP Upcoming EarningsAcurx Pharmaceuticals' next earnings date is estimated for Friday, August 8, 2025, based on past reporting schedules. Powered by Get Acurx Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acurx Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataACXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Acurx Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.14-$0.14-$0.14Q2 20251-$0.10-$0.10-$0.10Q3 20251-$0.11-$0.11-$0.11Q4 20251-$0.12-$0.12-$0.12 Acurx Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/8/2025(Estimated)--------5/12/2025Q1 2025-$0.14-$0.11+$0.03-$0.11--3/17/2025Q4 2024-$0.18-$0.16+$0.02-$0.16--11/12/2024Q3 2024-$0.23-$0.17+$0.06-$0.17--8/9/2024Q2 2024-$0.28-$0.26+$0.02-$0.26--5/14/2024Q1 2024-$0.24-$0.28 -$0.04-$0.28--3/15/2024Q4 2023-$0.26-$0.38 -$0.12-$0.38--11/13/2023Q3 2023-$0.28-$0.24+$0.04-$0.24--8/14/2023Q2 2023-$0.29-$0.28+$0.01-$0.28-- Acurx Pharmaceuticals Earnings - Frequently Asked Questions When is Acurx Pharmaceuticals's earnings date? Acurx Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 8th, 2025 based off last year's report dates. Learn more on ACXP's earnings history. Did Acurx Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Acurx Pharmaceuticals (NASDAQ:ACXP) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.03. Learn more on analysts' earnings estimate vs. ACXP's actual earnings. How can I listen to Acurx Pharmaceuticals's earnings conference call? The conference call for Acurx Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Acurx Pharmaceuticals's conference call transcript? The conference call transcript for Acurx Pharmaceuticals's latest earnings report can be read online. Read Transcript How much profit does Acurx Pharmaceuticals generate each year? Acurx Pharmaceuticals (NASDAQ:ACXP) has a recorded net income of -$14.58 million. ACXP has generated -$0.70 earnings per share over the last four quarters. What is Acurx Pharmaceuticals's EPS forecast for next year? Acurx Pharmaceuticals's earnings are expected to decrease from ($0.89) per share to ($2.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies Acrivon Therapeutics Earnings Date Aligos Therapeutics Earnings Date Estrella Immunopharma Earnings Date FibroBiologics Earnings Date OS Therapies Earnings Date Barinthus Biotherapeutics Earnings Date Quantum Biopharma Earnings Date LAVA Therapeutics Earnings Date Coeptis Therapeutics Earnings Date Scilex Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:ACXP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.